Home › Funds › ACT Capital Partners, L.P. › ANL

ACT Capital Partners, L.P. position in ANL

ADLAI NORTYE LTD · Health Care

ACT Capital Partners, L.P. reported holding 24,400 shares of ANL (ADLAI NORTYE LTD) in its Q3 2026 13F filing — a position valued at US$430K, representing 0.29% of its reported portfolio and ranking #35 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.

Latest position (Q3 2026)24.40K sh
Reported value held$430.40K
Portfolio Weight0.29%
First reportedQ3 2026
Last changeNew
Updated2026-11-07

Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR

How ACT Capital Partners, L.P.'s ANL position evolved

ACT Capital Partners, L.P. first disclosed a stake in ANL in Q3 2026 at 24,400 shares (US$430K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 24.40K $430.40K New

About ANL and 13F data

ANL (ADLAI NORTYE LTD) is a Health Care company. 42 other funds we track also report a position in ANL — the largest reported positions include Cormorant Asset Management, LP (US$45.7M), Venrock Adviser, LLC (US$36.9M), MPM BioImpact LLC (US$22.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANL

All ANL fund holders →

FAQ

How long has ACT Capital Partners, L.P. held ANL?

ACT Capital Partners, L.P. has disclosed ANL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is ACT Capital Partners, L.P.'s current position in ANL?

As of Q3 2026, ACT Capital Partners, L.P. holds 24.40K shares of ANL (ADLAI NORTYE LTD), valued at $430.40K, representing 0.29% of its reported portfolio and ranking #35.

Has ACT Capital Partners, L.P. been buying or selling ANL?

In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in ANL.

Which other funds hold ANL?

Other major institutional holders of ANL include Cormorant Asset Management, LP, Venrock Adviser, LLC, MPM BioImpact LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.